Supravalvular Aortic Stenosis
Also known as: SVAS
Supravalvular aortic stenosis (SVAS) is a fixed narrowing of the ascending aorta that starts at the sinotubular junction. It takes three forms: a localised hourglass narrowing (the most frequent), a discrete fibrous membrane, and diffuse hypoplasia of the ascending aorta that may extend into the arch and its branches.
The cause is loss of function of the elastin gene (ELN, chromosome 7q11.23). This occurs either as an isolated autosomal dominant mutation with variable penetrance, or as part of the contiguous deletion of Williams-Beuren syndrome (about 1 in 7,500 to 10,000 live births), in which about half or more of patients have SVAS.
Associated lesions are peripheral and supravalvular pulmonary stenosis, renal artery and mid-aortic narrowing, mitral valve prolapse and bicuspid aortic valve.
Pathophysiology. Elastin deficiency produces a thickened media with smooth muscle hyperplasia, disorganised elastic lamellae and intimal thickening, so the vessel is stiff and narrow. The fixed obstruction causes concentric left ventricular hypertrophy.
Because the narrowing lies distal to the valve, the coronary ostia sit in the high pressure zone. The coronary arteries become dilated and tortuous, and the aortic leaflets can tether to the narrowed ridge and obstruct ostial flow.
Coronary perfusion depends on diastolic pressure and falls with tachycardia, hypovolaemia and vasodilatation. The consequences are subendocardial ischaemia, ventricular arrhythmia and sudden death, especially during anaesthesia or sedation in Williams-Beuren syndrome.
The stenotic jet is directed towards the innominate artery (Coanda effect), so right arm systolic pressure exceeds left arm pressure by 10 mm Hg or more.













